Literature DB >> 7685013

The alpha v beta 5 integrin receptor regulates receptor-mediated endocytosis of vitronectin.

T S Panetti1, P J McKeown-Longo.   

Abstract

Vitronectin is an adhesive glycoprotein that binds to the extracellular matrix and interacts with integrin receptors on the surface of adherent cells. Previous studies have demonstrated that the conformationally altered, heparin binding form of vitronectin is removed from the matrix by receptor-mediated endocytosis and degraded through a lysosomal pathway (Panetti, T. S., and McKeown-Longo, P. J. (1993) J. Biol. Chem. 268, 11988-11993). The present studies were undertaken to determine the role of cell surface integrins in the endocytosis and degradation of vitronectin. RGDS peptides, used to disrupt the binding of vitronectin to cell surface integrins, inhibited degradation of vitronectin but had no effect on the binding of vitronectin to the cell layer. Localization of vitronectin in the cell layer by indirect immunofluorescence indicated that the RGDS peptides inhibited degradation by preventing the internalization of vitronectin by the cells. To determine which vitronectin receptor was involved in mediating the endocytosis, vitronectin degradation was measured in the presence of monoclonal antibodies. Antibodies against the alpha v beta 5 but not the alpha v beta 3 integrin inhibited degradation of vitronectin by 80%. This study demonstrates a new role for integrins in regulating internalization and degradation of molecules from the extracellular matrix.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685013

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

2.  The integrin alphavbeta5 is expressed on avian osteoclast precursors and regulated by retinoic acid.

Authors:  K Sago; S L Teitelbaum; K Venstrom; L F Reichardt; F P Ross
Journal:  J Bone Miner Res       Date:  1999-01       Impact factor: 6.741

3.  Vitronectin mediates internalization of Neisseria gonorrhoeae by Chinese hamster ovary cells.

Authors:  T D Duensing; J P van Putten
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Pharmacoproteomic analysis of a novel cell-permeable peptide inhibitor of tumor-induced angiogenesis.

Authors:  Ji-Young Bang; Eung-Yoon Kim; Dong-Ku Kang; Soo-Ik Chang; Moon-Hi Han; Kwang-Hyun Baek; In-Cheol Kang
Journal:  Mol Cell Proteomics       Date:  2011-05-10       Impact factor: 5.911

5.  Alphav integrins mediate adhesion and migration of breast carcinoma cell lines.

Authors:  N C Wong; B M Mueller; C F Barbas; P Ruminski; V Quaranta; E C Lin; J W Smith
Journal:  Clin Exp Metastasis       Date:  1998-01       Impact factor: 5.150

6.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

7.  The role of the adenovirus protease on virus entry into cells.

Authors:  U F Greber; P Webster; J Weber; A Helenius
Journal:  EMBO J       Date:  1996-04-15       Impact factor: 11.598

8.  The first step of adenovirus type 2 disassembly occurs at the cell surface, independently of endocytosis and escape to the cytosol.

Authors:  M Y Nakano; K Boucke; M Suomalainen; R P Stidwill; U F Greber
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

9.  Loss of RPE phenotype affects phagocytic function.

Authors:  Wei Feng; Jing J Zheng; Douglas A Lutz; Barbara J McLaughlin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-02-18       Impact factor: 3.117

10.  Caveolin-1-dependent beta1 integrin endocytosis is a critical regulator of fibronectin turnover.

Authors:  Feng Shi; Jane Sottile
Journal:  J Cell Sci       Date:  2008-06-24       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.